Variant report
Variant | nsv470513 |
---|---|
Chromosome Location | chr2:212852669-212874828 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1155683 | chr2:212852669-212852670 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs80153874 | chr2:212852704-212852705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550445688 | chr2:212852718-212852719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs186251500 | chr2:212852731-212852732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147982423 | chr2:212852747-212852748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550891420 | chr2:212852750-212852751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560923427 | chr2:212852835-212852836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189914302 | chr2:212852845-212852846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs34902199 | chr2:212852854-212852855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76476307 | chr2:212852866-212852867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2860059 | chr2:212852895-212852896 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs111522617 | chr2:212852948-212852949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs141072908 | chr2:212852953-212852954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551868479 | chr2:212852957-212852958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs58791698 | chr2:212853026-212853027 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs181508367 | chr2:212853029-212853030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144901267 | chr2:212853040-212853041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574254286 | chr2:212853073-212853074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs186985059 | chr2:212853092-212853093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546634164 | chr2:212853094-212853095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553168012 | chr2:212853126-212853127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572975508 | chr2:212853174-212853175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545130410 | chr2:212853176-212853177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs138648979 | chr2:212853178-212853179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141775580 | chr2:212853213-212853214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs564712258 | chr2:212853250-212853251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs544281165 | chr2:212853289-212853290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs16847425 | chr2:212853298-212853299 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs150636685 | chr2:212853317-212853318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138847063 | chr2:212853348-212853349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs560419182 | chr2:212853349-212853350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7566569 | chr2:212853399-212853400 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs190688721 | chr2:212853435-212853436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371999638 | chr2:212853467-212853468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs368848640 | chr2:212853498-212853499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs149349583 | chr2:212853533-212853534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567586761 | chr2:212853535-212853536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs17336823 | chr2:212853548-212853549 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs537259381 | chr2:212853581-212853582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183205208 | chr2:212853633-212853634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557806211 | chr2:212853637-212853638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144652031 | chr2:212853671-212853672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538751693 | chr2:212853675-212853676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs186407510 | chr2:212853722-212853723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575659608 | chr2:212853744-212853745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs373727389 | chr2:212853761-212853762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554686076 | chr2:212853793-212853794 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541599595 | chr2:212854665-212854666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561341359 | chr2:212854755-212854756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs375483051 | chr2:212854770-212854771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Schizophrenia | 20838587 | CNVD |
Breast cancer | 17661082 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Schizophrenia | 18990708 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:212847400-212853000 | Weak transcription | Fetal Heart | heart |
2 | chr2:212853000-212853800 | Enhancers | Fetal Heart | heart |
3 | chr2:212854600-212855200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr2:212859400-212859800 | Enhancers | Skeletal Muscle Male | skeletal muscle |
5 | chr2:212859400-212859800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
6 | chr2:212861400-212861800 | Enhancers | GM12878-XiMat | blood |
7 | chr2:212865000-212865200 | Enhancers | Brain Hippocampus Middle | brain |
8 | chr2:212865200-212865800 | Weak transcription | Brain Hippocampus Middle | brain |
9 | chr2:212865800-212866400 | Enhancers | Brain Anterior Caudate | brain |
10 | chr2:212865800-212866600 | Enhancers | Brain Hippocampus Middle | brain |
11 | chr2:212872600-212874400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr2:212874200-212874800 | Enhancers | Brain Angular Gyrus | brain |
13 | chr2:212874400-212875800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |